Identification of Activated Cdc42-Associated Kinase Inhibitors as Potential Anticancer Agents Using Pharmacoinformatic Approaches
Biomolecules · 22.01.2023 · 13 (2) · 217
DOI: 10.3390/biom13020217 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 22.01.2023. Verfasst von Vikas Kumar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bio & Medical Big Data (BK4 Program), Division of Life Science, Research Institute of Natural Science (RINS), Gyeongsang National Unive…. Hauptthemen laut MEDLINE: Protein-Tyrosine Kinases, Antineoplastic Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, National Research Foundation of Republic of Korea (NRF).
Abstract (Originalsprache)
Background
Activated Cdc42-associated kinase (ACK1) is essential for numerous cellular functions, such as growth, proliferation, and migration. ACK1 signaling occurs through multiple receptor tyrosine kinases; therefore, its inhibition can provide effective antiproliferative effects against multiple human cancers. A number of ACK1-specific inhibitors were designed and discovered in the previous decade, but none have reached the clinic. Potent and selective ACK1 inhibitors are urgently needed.
Methods
In the present investigation, the pharmacophore model (PM) was rationally built utilizing two distinct inhibitors coupled with ACK1 crystal structures. The generated PM was utilized to screen the drug-like database generated from the four chemical databases. The binding mode of pharmacophore-mapped compounds was predicted using a molecular docking (MD) study. The selected hit-protein complexes from MD were studied under all-atom molecular dynamics simulations (MDS) for 500 ns. The obtained trajectories were ranked using binding free energy calculations (ΔG kJ/mol) and Gibb’s free energy landscape.
Results
Our results indicate that the three hit compounds displayed higher binding affinity toward ACK1 when compared with the known multi-kinase inhibitor dasatinib. The inter-molecular interactions of Hit1 and Hit3 reveal that compounds form desirable hydrogen bond interactions with gatekeeper T205, hinge region A208, and DFG motif D270. As a result, we anticipate that the proposed scaffolds might help in the design of promising selective ACK1 inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bio & Medical Big Data (BK4 Program), Division of Life Science, Research Institute of Natural Science (RINS), Gyeongsang National University (GNU), 501 Jinju-daero, Jinju 52828, Republic of Korea.
- ANGEL i-Drug Design (AiDD), Jinju 52828, Republic of Korea.
- Department of Biotechnology and Bioinformatics, Jaypee University of Information Technology, Waknaghat, Solan 173 234, Himachal Pradesh, India.
- Division of Applied Life Science, Plant Molecular Biology and Biotechnology Research Center (PMBBRC), Gyeongsang National University (GNU), 501 Jinju-daero, Jinju 52828, Republic of Korea.
- Department of Chemistry and Molecular Biology, University of Gothenburg, 405 30 Göteborg, Sweden.
- Division of Applied Life Science (BK21 Four), ABC-RLRC, PMBBRC, Gyeongsang National University, Jinju 52828, Republic of Korea.
ORCID-Profile: Vikas Kumar, Shraddha Parate, Moonhyuk Kwon, Hyeon-Su Ro
Förderung
- National Research Foundation of Korea
- National Research Foundation of Republic of Korea (NRF)
Zitieren
APA
Kumar, V., Kumar, R., Parate, S., Danishuddin, Lee, G., Kwon, M., Jeong, S. H., Ro, H. S., Lee, K. W., & Kim, S. W. (2023). Identification of Activated Cdc42-Associated Kinase Inhibitors as Potential Anticancer Agents Using Pharmacoinformatic Approaches. Biomolecules, 13(2), 217. https://doi.org/10.3390/biom13020217
Vancouver
Kumar V, Kumar R, Parate S, Danishuddin, Lee G, Kwon M, et al. Identification of Activated Cdc42-Associated Kinase Inhibitors as Potential Anticancer Agents Using Pharmacoinformatic Approaches. Biomolecules. 2023;13(2):217. doi:10.3390/biom13020217
BibTeX
@article{Kumar2023,
author = {Kumar, Vikas and Kumar, Raj and Parate, Shraddha and Danishuddin and Lee, Gihwan and Kwon, Moonhyuk and Jeong, Seong-Hee and Ro, Hyeon-Su and Lee, Keun Woo and Kim, Seon-Won},
title = {Identification of Activated Cdc42-Associated Kinase Inhibitors as Potential Anticancer Agents Using Pharmacoinformatic Approaches},
journal = {Biomolecules},
year = {2023},
volume = {13},
number = {2},
pages = {217},
doi = {10.3390/biom13020217}
}
EUVIMED